SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-020340
Filing Date
2020-03-19
Accepted
2020-03-19 19:00:12
Documents
2
Period of Report
2020-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1525
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3851
  Complete submission text file 0001209191-20-020340.txt   6749
Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Enyedy Mark J (Reporting) CIK: 0001586965 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38707 | Film No.: 20729829

Mailing Address 99 ERIE STREET CAMBRIDGE MA 02139
Business Address 99 ERIE STREET CAMBRIDGE MA 02139 617-245-0399
LogicBio Therapeutics, Inc. (Issuer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)